INTRODUCTION
Barringtonia racemosa (B. racemosa) (familyBarringtoniaceae) is a tall tree with one seeded, ovoid fruits, distributed in eastern and western seacoasts of India. The fruit pulp of B. racemosa had been in use as a fish poison. Apart from this, the plant is also used medicinally in treatment of diarrhoea, asthma, coughs, jaundice as well as an analgesic and antipyretic.
1,2 Some recent reports claim that B. racemosa possesses significant anti-tumor activity. 3 However, systematic evaluation of its immunomodulatory effects has not been reported. In present investigation the hydroalcoholic extract of fruits of B. racemosa has been evaluated for its immunomodulatory properties in animal models.
METHODS

Preparation of extracts
Fruits of B. racemosa were purchased from a local vendor and were authenticated at Botanical Survey of India, Pune, India. The fruits were coarsely powdered and macerated with methanol: water (1:1) for 8 hours with frequent stirring. At the end of maceration, the extract was filtered and the filtrate was dried under vacuum in a rotary evaporator under reduced pressure at 40 0 C-45 0 C. 
Animals used
Healthy albino Wistar rats of either sex having 110-160 g body weight were used for this study. The rats were housed in polypropylene cages and maintained under standard conditions (12 hrs light and dark cycles, at 25±3 0 C and 35-60% humidity). Standard palletized feed and tap water were provided ad libitum. The study was approved by the Institutional Animal Ethical Committee of R.C. Patel College of Pharmacy, Shirpur, India, registered under CPCSEA, India (Registration No. 651/02/C/CPCSEA).
Dosage and concentrations
Treatment with the fruit extract and standard drugs were given by intraperitoneal route. For preparation of drug solutions sterile pyrogen free saline was used and the solutions were filtered through 0.2 µ filter (Millipore) immediately before administration. As a standard drug, Cyclophosphamide at a dose of 50 mg/ kg body weight, given by intraperitoneal route was used. 4, 5 It was not administered for more than three to four days in any case.
Antigen
As an antigen, Sheep red blood cells (SRBCs) were used. Fresh sheep blood was collected and aseptically added to sterile Alsever's solution in 1:1 proportion. 6 Then the SRBCs were washed three times with pyrogen free sterile phosphate buffer saline (PBS) 7 and the count was adjusted approximately to 0.5 X 10 9 cells / ml.
8
Delayed type hypersensitivity reaction (DTH) using SRBCs
Eighteen wistar rats of either sex were divided into three groups consisting of six rats each. On day '0', animals in all the groups were immunized by intraperitoneal administration of 0.5 X 10 9 cells / ml/ 100gm of SRBCs suspension. Dosing of the animals as per assigned treatment schedule was started on the same day.
Negative control group received normal saline given by intraperitoneal route from day 0 to day 7 of the experiment; positive control group received no treatment till day 4 of experimentation. To this group, the drug cyclophosphamide (50 mg/ kg/ day; i.p.) was started on day 5 and was continued till day 7. The extract treated group was administered with hydroalcoholic extract of B. racemosa (5 mg/ kg/ day; i. p.) from day 0 to day 7. This dose of the extract was found to be non toxic in the primary studies carried out in our laboratory (results not included here) and also considering earlier reports on this plant.
On day 7, all the three groups of rats were challenged with 0.1 ml of 0.5 X 10 9 cells/ ml SRBCs in left hind foot pad, while contra lateral foot pad was injected with equal volume of normal saline. 4 The thickness of both foot pads in case of all the animals was measured at 0, 24, 48 hours plethysmometrically using digital Plethysmometer (UgoBasile 7140, Italy). 9 The difference in the volume of left paws at 0 hour and 48 hours was used as a measure of DTH reaction.
10,11
Humoral antibody response to SRBC Twenty four wistar rats of either sex were divided into four groups containing six rats in each. On the day '0' of experiment, rats in all the groups except naïve control group were immunized by intraperitoneal administration of 0.5 X 10 9 cells/ ml/ 100gm of SRBCs. 12 The rats were administered with the assigned treatments as stated above.
To standard drug treated group, Cyclophosphamide at dose of 50 mg/ kg/ day (i.p.) was administered on days 5, 6, 7.
On day 7, blood samples were collected from all treatment groups through retro orbital puncture. 5, 11 Serum was rapidly separated by centrifugation. In 'V' bottom 96 well microplates' two fold serial dilutions of 25µl serum samples in saline were prepared. The plates were incubated at 56 0 C for 30 minutes. At the end of the incubation period, 25 µl of 1% v/v SRBC suspension was added to each well. The microplates were shaken manually and further incubated at 37 0 C for 1 hr. The plates were then visually observed for haemagglutination titer. The minimum dilution showing button formation at the bottom of the well was taken as haemagglutination titer.
13,14
Statistical analysis
The data obtained was analyzed for statistical significance using one-way ANOVA followed by Bonferroni's Multiple Comparison test using Graphpad Prism 4.0 software.
RESULTS
Effect of hydroalcoholic extract on delayed type hypersensitivity reaction (DTH)
Fruits extract at the dose of 5 mg/kg i.p. showed significant decrease in DTH response as compared to that of control group animals. The DTH reaction was significantly inhibited in both cyclophosphamide and extract treated animals. However, the effect of extract was less potent as compared to that of cyclophosphamide treated group (Figure 1 ). 
Effect on humoral antibody
In haemagglutination titer assay, antibody titer in case naïve control, SRBC treated, cyclophosphamide treated and extract treated groups was 1:1, 1:32, 1:8 and 1:16 respectively. Such decrease in the titer value indicates that hydroalcoholic extract causes suppression of antibody formation against the injected SRBCs (Table 1) . 
DISCUSSION
B. racemosa plant has been reported to possess numerous biological activities like anti-tumor activity and antiasthmatic activity which point towards possible immunomodulatory activity of this plant. In present study, the fruit extract of this plant has been investigated in invivo and in vitro experimental models related to immune system activity.
At the dose of 5 mg/ kg, the hydroalcoholic fruit extract of B. racemosa significantly reduced the intensity of delayed type hypersensitivity induced by SRBC as antigen. Similarly, SRBC induced antibody titer was significantly reduced. These observations are coherent with its anti-tumor and anti-asthmatic effects. It is proposed that, the extracts of B. racemosa studied in present investigation may be further fractionated and investigated using more sensitive in vivo and in vitro models related to immune system disorders.
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